Get started
Author

Daniel M. Klass

Integrated digital error suppression for improved detection of circulating tumor DNA
2016 · Aaron M Newman, Alexander F Lovejoy, et al. · Nature Biotechnology · 1,101
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
2016 · Florian Scherer, David M. Kurtz, et al. · Science Translational Medicine · 484
Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus
2006 · Susanne M Clee, Brian S Yandell, et al. · Nature Genetics · 168
Proteome-Wide Search Reveals Unexpected RNA-Binding Proteins in Saccharomyces cerevisiae
2010 · Nikoleta G. Tsvetanova, Daniel M. Klass, et al. · PLoS ONE · 157
PDF
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
2022 · Diana Merino Vega, Katherine K. Nishimura, et al. · JCO Precision Oncology · 75
PDF
ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials
2019 · Johannes Noé, Alex Lovejoy, et al. · Journal of Thoracic Oncology · 58
Quantitative proteomic analysis reveals concurrent RNA–protein interactions and identifies new RNA-binding proteins in Saccharomyces cerevisiae
2013 · Daniel M. Klass, Marion Scheibe, et al. · Genome Research · 58
PDF
Identification and genetic manipulation of human and mouse oesophageal stem cells
2015 · Youngtae Jeong, Horace Rhee, et al. · Gut · 45
Whi3, an S. cerevisiae RNA-Binding Protein, Is a Component of Stress Granules That Regulates Levels of Its Target mRNAs
2013 · Kristen J. Holmes, Daniel M. Klass, et al. · PLoS ONE · 23
PDF
Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC
2022 · Milou Schuurbiers, Zhongyun Huang, et al. · Journal for ImmunoTherapy of Cancer · 20
PDF
Quantitative PCR–Based Method to Assess Cell-Free DNA Quality, Adjust Input Mass, and Improve Next-Generation Sequencing Assay Performance
2022 · Seng Lor Saelee, Alexander F. Lovejoy, et al. · Journal of Molecular Diagnostics · 13
Pooled mutation analysis for the NP28673 and NP28761 studies of alectinib in ALK+ non-small-cell lung cancer (NSCLC).
2016 · Oscar Puig, James Chih-Hsin Yang, et al. · Journal of Clinical Oncology · 12
Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma
2015 · Florian Scherer, David M. Kurtz, et al. · Blood · 10
Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma
2015 · David M. Kurtz, Florian Scherer, et al. · Blood · 9
Molecular Characteristics and Disease Burden Metrics Determined By Next-Generation Sequencing on Circulating Tumor DNA Correlate with Progression Free Survival in Previously Untreated Diffuse Large B-Cell Lymphoma
2019 · Ehsan Tabari, Alexander F Lovejoy, et al. · Blood · 5
Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics.
2016 · David Matthew Kurtz, Florian Scherer, et al. · Journal of Clinical Oncology · 5
Noninvasive molecular subtyping and risk stratification of DLBCL.
2016 · Florian Scherer, David Matthew Kurtz, et al. · Journal of Clinical Oncology · 2
Improved Discovery of Molecular Interactions in Genome-Scale Data with Adaptive Model-Based Normalization
2013 · Julia Salzman, Daniel M. Klass, et al. · PLoS ONE · 2
PDF
Abstract 3379: Assessment of tumor mutation burden using a novel panel design strategy utilizing highly mutated genomic regions
2019 · Amrita Pati, Daniel Klass, et al. · Bioinformatics, Convergence Science, and Systems Biology · 1
Changes in circulating tumor DNA levels are associated with treatment response and progression-free survival in relapse/refractory DLBCL subjects.
2019 · Alexander F. Lovejoy, Hai Lin, et al. · Journal of Clinical Oncology · 1
Mutation count, a potential surrogate for tumor mutation load, of circulating tumor DNA (ctDNA) using targeted panel sequencing correlates with clinical outcomes in late stage lung adenocarcinoma and small cell lung cancer.
2018 · Stephanie Yaung, Liu Xi, et al. · Journal of Clinical Oncology · 1
Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC.
2016 · Aaron M. Newman, Alexander F. Lovejoy, et al. · Journal of Clinical Oncology · 1
Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated With Chemoradiation Therapy
2015 · D. Klass, A. Newman, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma
2014 · E. Osmundson, A.M. Newman, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
OC-0270 Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations
2023 · S. Kroeze, M. Pavic, et al. · Radiotherapy and Oncology
Works count: 36
Citation count: 2,253
H-index: 12
I10-index: 13
Year
Topic
Type